Serum Institute of India

The Serum Institute of India (SII) on Tuesday said that it will produce additional 100 million COVID-19 vaccine doses for India and low a...Read More

Mumbai At a time when the debate is underway on the timing of launch of Covid-19 vaccines, Adar Poonawalla, CEO of Serum Institute of Ind...Read More

The Serum Institute of India (SII) is all set to begin phase three trials of the of University of Oxford and AstraZeneca Plc.’s experimen...Read More

The CEO of the Serum Institute of India (SII) Adar Poonawalla has warned of shortage of the COVID-19 vaccine for all till 2024.In an inte...Read More

The Serum Institute of India has paused trials till further instructions from the DCGI after getting a show-cause notice.The phase 2/3 CO...Read More

The central drug regulator has issued a show-cause notice to Serum Institute of India (SII) for not informing it about pharma giant Astra...Read More

The Phase II clinical trial of the Oxford COVID-19 vaccine, being manufactured by the city-based Serum Institute of India (SII), began at...Read More

After several reports around the manufacturing of COVID-19 vaccine, Serum Institute of India, which has partnered with Oxford University ...Read More

Serum Institute of India (SII) on Friday said it has entered into a new partnership with international vaccine alliance Gavi and Bill &a...Read More

New Delhi: Serum Institute of India (SII) on Friday said it has entered into a new partnership with international vaccine alliance Gavi a...Read More

On Monday, the world was buzzing with hope after scientists at the University of Oxford announced that a vaccine that has been developed ...Read More

Vaccine maker Serum Institute of India (SII) is hoping to develop a COVID-19 vaccine by the year-end as it is focusing on a "good and saf...Read More

The Serum Institute of India, part of the Cyrus Poonawalla group, is a key global player in the vaccine space. From being seen as a mass ...Read More